Author

Rick Riemens

Vrije Universiteit Amsterdam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andy ChevignéiD· 1 shared Desislava N. NeshevaiD· 1 shared Henry F. VischeriD· 1 shared Iwan J. P. de EschiD· 1 shared Justyna M. AdamskaiD· 1 shared Maikel WijtmansiD· 1 shared Martyna SzpakowskaiD· 1 shared Maurice C. M. L. BuzinkiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andy ChevignéORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyMolecular PharmacologyPeer-reviewedOct 26, 2025

Inhibition of constitutive activity of the atypical chemokine receptor ACKR3 by the small-molecule inverse agonist VUF16840

Reggie Bosma, Desislava N. Nesheva, Merel Rijnsburger…·Rob Leurs

This study characterizes VUF16840 as a selective inverse agonist of ACKR3 that inhibits constitutive and chemokine-induced signaling by stabilizing the inactive conformation of the receptor.

5 citations

humanexperimental assay

𝕏 PostBluesky